Nestlé Launching Frozen Food Brand For Ozempic Users [Forbes]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Forbes
Tuesday, part of the food giant's to offset potential sales losses as appetite-suppressing drugs grow popular. The frozen food line, dubbed Vital Pursuit, will feature a variety of nutrient-dense meal options ... [+] priced at $4.99 and under. The frozen food line, dubbed , will be priced at $4.99 and under and feature products like frozen pizza, sandwich melts and pasta. Vital Pursuit will be packed with a variety of nutrients, such as protein, vitamin A, potassium and calcium, and also will offer gluten-free options, Tuesday's said. The food line's packaging will not explicitly mention GLP-1 drugs, reported, but Nestlé will make such connections on social media—and the company mentioned GLP-1s in its press release. Nestlé USA Meals Division President Tom Moe in a statement the company has been expanding its offerings to address consumer eating habits, adding as “the market evolves, we'll continue to expand Vital Pursuit with more product formats for our consumers.” Vital
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $22.00 to $26.00. They now have a "buy" rating on the stock.MarketBeat
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $17.25 to $22.00. They now have a "buy" rating on the stock.MarketBeat
- Hims & Hers Health Stock Soared This Week: Here's Why [Yahoo! Finance]Yahoo! Finance
- The Ultimate Growth Stock to Buy With $20 Right Now [Yahoo! Finance]Yahoo! Finance
- Reasons to Include Alcon (ALC) in Your Portfolio Right Now [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 5/6/24 - Beat
HIMS
Sec Filings
- 6/13/24 - Form 144
- 6/12/24 - Form 4
- 6/12/24 - Form 4
- HIMS's page on the SEC website